ERBB2 and metastatic malignant neoplasm in the lymph nodes: 236 (56.6%) patients had lymph node metastasis, 193 (46.3%) of the tumors were positive for ER, 178 (42.7%) were positive for PR, and 154 (36.9%) showed HER2 overexpression.